middle.news
Percheron’s 280 million options put HMBD-002 funding within reach
8:37am on Wednesday 4th of November, 2026 AEDT
•
Biotechnology and Pharmaceuticals
Read Story
Percheron’s 280 million options put HMBD-002 funding within reach
8:37am on Wednesday 4th of November, 2026 AEDT
Key Points
Up to 280 million options offered to placement participants and lead managers
$0.01 exercise price with expiry on 15 April 2028
Potential exercise proceeds of approximately $2.8 million before costs
Shares issued on exercise could represent about 12% of the post-offer share count
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Percheron Therapeutics (ASX:PER)
OPEN ARTICLE